Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical

Sep 06, 2023 7:45am EDT

Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 24, 2023 7:30am EDT

Aptose Reports Results for the Second Quarter 2023

Aug 10, 2023 4:02pm EDT

Aptose to Report Second Quarter 2023 Financial Results and Hold Conference Call on Thursday, August 10, 2023

Jul 27, 2023 4:04pm EDT

Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance

Jun 26, 2023 4:05pm EDT

Aptose Presents Highlights from Clinical Update

Jun 10, 2023 12:00pm EDT

Aptose Biosciences Provides Update on Reverse Stock Split

Jun 05, 2023 7:30am EDT

Aptose to Hold Interim Clinical Update Webcast on Saturday, June 10, 2023

May 31, 2023 7:30am EDT

Aptose Enters into $25 Million Committed Equity Facility

May 25, 2023 4:14pm EDT

Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders

May 23, 2023 5:30pm EDT